Novo Nordisk shares rose after the Danish obesity-drug maker's first-quarter earnings topped Wall Street expectations. As widely anticipated, the drug maker reduced its growth forecast to reflect the ...

U.S. President Donald Trump is expected to sign an executive order as early as next week that would revive an effort to ...

Novo Nordisk stock jumped early Wednesday despite cutting its 2025 outlook due to what Novo says is illegal compounding of ...

Shares of Novo Nordisk climbed nearly 7% on Wednesday after the company said sales of its obesity drug Wegovy are expected to ...

Pharmaceutical company Charles River Laboratories has reached a settlement with activist investor Elliott Investment ...

Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...

The U.S. Food and Drug Administration said on Wednesday it will hold a meeting of experts to discuss COVID-19 vaccine ...

Novo Nordisk reports its results in Danish kroner (DKK) rather than U.S. dollars. Sales grew 19% year over year to 78.1 ...

A U.S. federal judge has sided with a U.S. regulator's decision last year to take Eli Lilly’s blockbuster weight loss and ...

Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...

U.S. Agriculture Secretary Brooke Rollins said during a hearing in the House of Representatives on Wednesday that new dietary ...

India's central bank on Wednesday laid down a framework to standardise the process of making and amending rules, including ...